-Mira Jung Researcher Activity Profile

Research Author Detailed Information 

Mira Jung Publication Rate By Year

Mira Jung has published 1 paper(s) in 1959, 1 paper(s) in 1969, 1 paper(s) in 1987, 1 paper(s) in 1988, 1 paper(s) in 1989, 1 paper(s) in 1990, 2 paper(s) in 1991, 1 paper(s) in 1996, 1 paper(s) in 1998, 1 paper(s) in 2002, 3 paper(s) in 2003, 1 paper(s) in 2004, 1 paper(s) in 2006, 31 paper(s) in 2007, 10 paper(s) in 2008, for a total of 57 research publications in total.

Mira M Jung Author Information

LAST NAME: jung

FIRST NAME: Mira

INITIALS: m

AFFILIATION:

Papers

Mira Jung's Publication Record

1. Rational design and development of radiation-sensitizing histone deacetylase inhibitors. Year Published: 2006
Department of Radiation Medicine, Georgetown University Medical Center, The Research Building, Room E202, Box 571482, 3970 Reservoir Road NW, Washington, DC 20057-1482, USA.
2. An Wearable Energy Expenditure Analysis System based on the 15-channel Whole-body Segment Acceleration Measurement. Year Published: 2007
Interdisciplinary Program, Biomedical Engineering Major, Graduate School, Seoul National University, Seoul, Korea.
3. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation. Year Published: 2007
Department of Radiation Medicine, Georgetown University Medical Center, Washington, DC 20057-1482, USA.
4. Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors. Year Published: 2007
Department of Chemistry, Yonsei University, Seoul 120-749, Republic of Korea. mjung@yonsei.ac.kr
5. Attenuated DNA damage repair by trichostatin A through BRCA1 suppression. Year Published: 2007
Division of Radiation Research, Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
6. Characterization of novel inhibitors of histone acetyltransferases. Year Published: 2007
Division of Radiation Research, Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
7. [In Process Citation] Year Published: 2007
8. [In Process Citation] Year Published: 2007
9. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Year Published: 2007
Division of Biotechnology, College of Life Sciences and Biotechnology, Seoul National University Hospital, Seoul, Korea.
10. [Outcome of arthroscopic resection of labral tears] Year Published: 2007
11. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Year Published: 2007
Department of Chemistry, Yonsei University, Seoul 120-749, Korea. mjung@yonsei.ac.kr
12. R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. Year Published: 2007
1Oncology Research, Johnson & Johnson Pharmaceutical Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
13. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Year Published: 2007
Department of Chemistry, Yonsei University, Seoul 120-749, Korea. mjung@yonsei.ac.kr
14. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library. Year Published: 2007
Tumor Biology Center, Breisacher Strasse 117, 79106, Freiburg, Germany.
15. [Reconstruction of phalanx and metacarpal defects by autologous iliac crest transplants after tumour resection with joint involvement.] Year Published: 2007
16. R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. Year Published: 2007
Oncology Research, Johnson & Johnson Pharmaceutical Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium. jarts@prdbe.jnj.com
17. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. Year Published: 2007
Department of Experimental Pathology, IIBB-CSIC, IDIBAPS, 08036 Barcelona, Spain.
18. Complex formation of p65/RelA with nuclear Akt1 for enhanced transcriptional activation of NF-kappaB. Year Published: 2007
Functional Metabolomics Research Center, KRIBB, Yuseong, Daejeon, Republic of Korea.
19. Comprehensive analysis of time- and dose-dependent patterns of gene expression in a human mesenchymal stem cell line exposed to low-dose ionizing radiation. Year Published: 2007
Division of Radiation Effect Research, Radiation Health Research Institute of KHNP, Seoul 132-703, Korea.
20. [Outcome of arthroscopic resection of labral tears] Year Published: 2007
21. R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. Year Published: 2007
Oncology Research, Johnson & Johnson Pharmaceutical Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium. jarts@prdbe.jnj.com
22. Complex formation of p65/RelA with nuclear Akt1 for enhanced transcriptional activation of NF-kappaB. Year Published: 2007
Functional Metabolomics Research Center, KRIBB, Yuseong, Daejeon, Republic of Korea.
23. Comprehensive analysis of time- and dose-dependent patterns of gene expression in a human mesenchymal stem cell line exposed to low-dose ionizing radiation. Year Published: 2007
Division of Radiation Effect Research, Radiation Health Research Institute of KHNP, Seoul 132-703, Korea.
24. A note on the transmission of the inclusion producing agent of trachoma by means of material stored at -60 degrees C. Year Published: 1959
25. Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type. Year Published: 2008
26. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Year Published: 2007
27. [In Process Citation] Year Published: 2007
28. [In Process Citation] Year Published: 2007
29. R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. Year Published: 2007
Oncology Research, Johnson & Johnson Pharmaceutical Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium. jarts@prdbe.jnj.com
30. Ruthenium-catalyzed alkene-alkyne coupling: synthesis of the proposed structure of amphidinolide A. Year Published: 2002
Department of Chemistry, Stanford University, Stanford, California 94305-5080, USA. bmtrost@stanford.edu
31. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library. Year Published: 2007
Tumor Biology Center, Breisacher Strasse 117, 79106, Freiburg, Germany.
32. [Reconstruction of phalanx and metacarpal defects by autologous iliac crest transplants after tumour resection with joint involvement] Year Published: 2007
33. [Scintigraphic studies with J123 miniplasmin in patients with suspected deep venous thrombosis of the leg: comparison of the diagnostic value of J123 miniplasmin scintigraphy and Tc99m plasmin test] Year Published: 1987
34. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. Year Published: 2007
Department of Experimental Pathology, IIBB-CSIC, IDIBAPS, 08036, Barcelona, Spain.
35. [Co-author and Keyword Networks and their Clustering Appearance in Preventive Medicine Fields in Korea: Analysis of Papers in the Journal of Preventive Medicine and Public Health, 1991~2006.] Year Published: 2008
Department of Medical Sociology, Graduate School of Public Health, Seoul National University, Korea. snu6449@anu.ac.kr.
36. [Virological studies on the explanation of intrauterine embryonal defects] Year Published: 1969
37. [Shaving of the cartilage: how much is healthy?] Year Published: 1996
Orthopädische Klinik, Kantonsspital Freiburg.
38. Comprehensive analysis of time- and dose-dependent patterns of gene expression in a human mesenchymal stem cell line exposed to low-dose ionizing radiation. Year Published: 2007
Division of Radiation Effect Research, Radiation Health Research Institute of KHNP, Seoul 132-703, Korea.
39. Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type. Year Published: 2008
Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany.
40. Microbiological risk of anaesthetic breathing circuits after extended use. Year Published: 2008
Institute of Medical Microbiology and Hygiene, Philipps University Marburg, Germany.
41. Linkage disequilibrium and sequence diversity in a 500-kbp region around the adh1 locus in elite maize germplasm. Year Published: 2004
Experimental Station, DuPont Crop Genetics, PO Box 80353, Wilmington, DE 19880-0353, USA. mark.t.jung@cgr.dupont.com
42. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. Year Published: 2007
Department of Experimental Pathology, IIBB-CSIC, IDIBAPS, 08036, Barcelona, Spain.
43. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). Year Published: 2008
Institute of Pharmaceutical Sciences, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
44. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). Year Published: 2008
Institute of Pharmaceutical Sciences, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
45. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts. Year Published: 2008
Korea Research Institute of Bioscience and Biotechnology, Yuseong, Daejeon, 305-806, Republic of Korea; College of Pharmacy, Chungnam National University, Yuseong, Daejeon 305-764, Republic of Korea.
46. [Effect of cellular growth factors on hepatocytes in experimental infection--regulation of NF-kappa B and glutathione homeostasis] Year Published: 2003
Chirurgische Klinik I, Sektion Chirurg. Forschung, Universitätsklinik Ulm.
47. [Tumor regression in long-term follow-up by administration of liposome encapsulated 5-FU. An animal experiment in WAF rats with CC-531 liver tumor] Year Published: 2003
Chirurgische Klinik I UKBF der FU Berlin.
48. [Liposome encapsulation of cystostatic drugs and starch microspheres improve tumor targeting in locoregional therapy. An animal experiment study of CC 531 liver tumor] Year Published: 2003
Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Abt. für Allgemein-, Gefäss- und Thoraxchirurgie, Hindenburgdamm 30, D-12200 Berlin.
49. [Risk of gastrectomy for stomach carcinoma in relation to reconstruction methods] Year Published: 1998
Chirurgische Klinik I, Universität Ulm.
50. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). Year Published: 2008
Institute of Pharmaceutical Sciences, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
51. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). Year Published: 2008
Institute of Pharmaceutical Sciences, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
52. [Mapping the capillary density of hands and feet in healthy probands] Year Published: 1988
53. [Assessment of thrombocyte deposits and thrombocyte survival following catheter dilatation of the lower extremities using 111-indium marked thrombocytes] Year Published: 1989
54. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease] Year Published: 1990
55. [Diagnosis of deep leg vein thrombosis--can we dispense with phlebography?] Year Published: 1991
Interne Abteilung, Evangelisches Krankenhaus Wien.
56. [Indications for percutaneous transluminal angioplasty and local thrombolysis in peripheral arterial occlusive disease] Year Published: 1991
Interne Abteilung, I. Medizinische Universitätsklinik, Wien.
57. Inhibitors of NAD+ dependent histone deacetylases (sirtuins). Year Published: 2008
Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg, Germany.